 |
|
Circulating Tumor DNA in a Breast Cancer Patient's Plasma Represents Driver Alterations in the Tumor Tissue
Jieun Lee, Sung-Min Cho, Min Sung Kim, Sug Hyung Lee, Yeun-Jun Chung, Seung-Hyun Jung
Genomics Inform. 2017;15(1):48-50. Published online 2017 Mar 29 DOI: https://doi.org/10.5808/GI.2017.15.1.48
|
|
Citations to this article as recorded by
 Concordance of Genomic Alterations between Circulating Tumor DNA and Matched Tumor Tissue in Chinese Patients with Breast Cancer
Bing Xu, Guangyu Shan, Qixi Wu, Weiwei Li, Hongjiang Wang, Hui Li, Yaping Yang, Qiming Long, Ping Zhao
Journal of Oncology.2020; 2020: 1. CrossRef Utility of Circulating Tumor DNA in Different Clinical Scenarios of Breast Cancer
Alexandra Mesquita, José Luís Costa, Fernando Schmitt
Cancers.2020; 12(12): 3797. CrossRef Liquid biopsy in breast cancer: A comprehensive review
Sahar Alimirzaie, Maryam Bagherzadeh, Mohammad R. Akbari
Clinical Genetics.2019; 95(6): 643. CrossRef Design of a Targeted Sequencing Assay to Detect Rare Mutations in Circulating Tumor DNA
Jianxia Chen, Jun Chen, Fusheng He, Yiqiong Huang, Shan Lu, Haibo Fan, Mingbang Wang, Ruihuan Xu
Genetic Testing and Molecular Biomarkers.2019; 23(4): 264. CrossRef Maximum allele frequency observed in plasma: A potential indicator of liquid biopsy sensitivity
Yong Tang, Xianling Liu, Zhu'an Ou, Zhe He, Qihang Zhu, Ye Wang, Mei Yang, Junyi Ye, Han Han‑Zhang, Guibin Qiao
Oncology Letters.2019;[Epub] CrossRef Quality Materials for Quality Assurance in the Analysis of Liquid Biopsy Samples
Jason C H Tsang, K C Allen Chan
Clinical Chemistry.2017; 63(9): 1431. CrossRef
|